ENDO PHARMACEUTICALS INC. v. TEVA PHARMACEUTICALS USA, INC.

Nos. 2015-2021, 2015-2022, 2015-2023, 2015-2024, 2015-2025, 2015-2026, 2015-2028, 2015-2031, 2015-2033, 2015-2034. 2015-2035, 2015-2041, 2015-2042, 2015-2046, 2015-2047, 2015-2049, 2015-2059, 2015-2060, 2016-1025, 2016-1060, 2016-1117, 2016-1118.

ENDO PHARMACEUTICALS INC., GRUNENTHAL GMBH, Plaintiffs-Cross-Appellants, v. TEVA PHARMACEUTICALS USA, INC., ACTAVIS INC., ACTAVIS SOUTH ATLANTIC LLC, WATSON PHARMACEUTICALS, INC., AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, ROXANE LABORATORIES, INC., AMNEAL PHARMACEUTICALS, LLC, THORX LABORATORIES, INC., BARR LABORATORIES, INC., RANBAXY, INC., RANBAXY PHARMACEUTICALS, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., IMPAX LABORATORIES, INC., Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: May 16, 2018.


Attorney(s) appearing for the Case

MARTIN JAY BLACK , Dechert LLP, Philadephia, PA, argued for plaintiff-cross-appellant Endo Pharmaceuticals Inc. Also represented by SHARON K. GAGLIARDI ; BLAKE GREENE , Austin, TX; JONATHAN LOEB , Mountain View, CA; ROBERT RHOAD , Princeton, NJ.

JOHN C. O'QUINN , Kirkland & Ellis LLP, Washington, DC, argued for all defendants-appellants. Defendant-appellants Actavis Inc., Actavis South Atlantic LLC, Watson Pharmaceuticals, Inc. also represented by WILLIAM H. BURGESS ; JAMES F. HURST , Chicago, IL; CHARLES A. WEISS , NICHOLAS P. CHIARA , HOWARD S. SUH , ERIC H. YECIES , Holland & Knight, LLP, New York, NY.

CHARLES E. LIPSEY , Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Reston, VA, for plaintiff-cross-appellant Grunenthal GMBH. Also represented by KRISTA E. BIANCO , JENNIFER HOWE ROSCETTI , ERIN MCGEEHAN SOMMERS , Washington, DC.

JACOB M. HOLDREITH , Robins Kaplan LLP, Minneapolis, MN, for defendants-appellants Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, LLC. Also represented by BRENDA L. JOLY , JAMIE R. KURTZ ; OREN D. LANGER , New York, NY.

ELIZABETH HOLLAND , Goodwin Procter LLP, New York, NY, for defendants-appellants Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc. Also represented by BRIAN ROBINSON , HUIYA WU .

MAUREEN L. RURKA , Winston & Strawn LLP, Chicago, IL, for defendants-appellants Impax Laboratories, Inc., Thorx Laboratories, Inc. Also represented by GEORGE C. LOMBARDI , KEVIN E. WARNER ; SCOTT R. SAMAY , New York, NY.

WILLIAM R. ZIMMERMAN , Knobbe, Martens, Olson & Bear, LLP, Washington, DC, for defendants-appellants Ranbaxy Pharmaceuticals, Inc., Ranbaxy, Inc., Sun Pharmaceutical Industries, Ltd. Also represented by CAROL PITZEL CRUZ , Seattle, WA.

ALAN B. CLEMENT , Locke Lord LLP, New York, NY, for defendant-appellant Roxane Laboratories, Inc. Also represented by HUGH S. BALSAM , SCOTT B. FEDER , MYOKA KIM GOODIN , Chicago, IL.

Before MOORE, BRYSON, and HUGHES,


This disposition is nonprecedential.

Endo Pharmaceuticals Inc. and Grünenthal GmbH sued generic drug manufacturers under the Hatch-Waxman Act in the U.S. District Court for the Southern District of New York, alleging infringement of, among other patents, U.S. Patent Nos. 8,309,122 B2 and 8,329,216 B2.

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases